Skip to content

Original Research

Frontiers in Veterinary Science ·

Volume 13 - 2026 | https://doi.org/10.3389/fvets.2026.1925752

Antimicrobial resistance profiling of Streptococcus suis isolated from neurological cases in Chilean pigs

  • Fernanda Larenas-Muñoz1
  • Francisca Videla-Martínez1
  • Álvaro Ruiz-Garrido1*corresponding author
  1. Departamento de Patología y Medicina Preventiva, Facultad de Ciencias Veterinarias, Universidad de Concepción, Chillán, Chile
Article metrics0 viewsView details

Abstract

Streptococcus suis is an important swine pathogen and an emerging zoonotic bacterium, with multidrug-resistant (MDR) strains representing an increasing concern for both animal and public health. This report describes the pathological findings and antimicrobial susceptibility profiles of MDR S. suis isolates recovered from the central nervous system of two pigs from a commercial swine farm in south-central Chile. Brain and spinal cord samples were examined by histopathology and microbiological culture, followed by bacterial identification and antimicrobial susceptibility testing using an antibiogram and minimum inhibitory concentration (MIC) analysis. Histopathological examination revealed non-suppurative inflammatory lesions characterized by mononuclear perivascular cuffing, consistent with meningoencephalomyelitis and myelitis. S. suis was isolated from the brain and/or spinal cord of both pigs. MIC testing demonstrated resistance to spectinomycin, ampicillin/amoxicillin, ceftiofur, penicillin, florfenicol, enrofloxacin, clindamycin, tilmicosin, tulathromycin, tylosin tartrate, tiamulin, sulfadimethoxine, trimethoprim/sulfamethoxazole, oxytetracycline, and chlortetracycline, indicating an MDR phenotype. Both isolates remained susceptible to gentamicin, while variable susceptibility was observed for danofloxacin, neomycin, tulathromycin, tiamulin, and trimethoprim/sulfamethoxazole. To the authors’ knowledge, this is the first report of MDR S. suis associated with neurological disease in pigs from Chile. These findings provide additional information on the antimicrobial susceptibility of S. suis in Chile and support the need for broader antimicrobial resistance surveillance under a One Health framework, as well as the prudent use of antimicrobials in swine production.

Keywords

1. Introduction

Streptococcus suis (S. suis) is a Gram-positive coccus classified into 29 serotypes and is part of the normal microbiota of pigs (1–4). These serotypes interact with additional determinants such as sequence types (STs), virulence profiles, and phylogenetic clades, all of which influence pathogenicity and transmission dynamics both within and between animal species (3–5). This pathogen commonly colonizes the upper respiratory tract, particularly the tonsils, which represent an important reservoir for infection (6, 7). However, due to its opportunistic and zoonotic nature, under certain predisposing conditions, it can invade the bloodstream and disseminate systemically, reaching organs such as the liver, heart, spleen, and kidneys via the bloodstream (6, 7). Furthermore, S. suis can cross the blood–brain barrier and invade the central nervous system, where infection primarily manifests as meningitis. In addition, bloodstream invasion and systemic dissemination may lead to sepsis and other clinical manifestations, including endocarditis, arthritis, and streptococcal toxic shock syndrome (8, 9).

Globally S. suis infections show a heterogeneous distribution, with a marked concentration of cases in Asia, particularly those associated with serotype 2 in countries such as China and Thailand (10, 11). This pattern has been linked to cultural practices such as the consumption of raw pork and high antimicrobial pressure in pig production systems (11, 12). Nevertheless, cases have also been reported in Europe and the Americas, suggesting a global distribution of the pathogen, although infections are likely underdiagnosed (13–15).

In this context, Chile represents an epidemiological setting of particular interest. Although available evidence remains limited, the presence of S. suis has been confirmed in both pigs and humans, particularly among occupationally exposed workers (16–18). The limited number of reports may reflect an underestimation of its occurrence in the country, potentially associated with limitations in microbiological surveillance and the clinical similarity of S. suis infection to other bacterial diseases (18).

However, despite growing knowledge of the epidemiology and pathogenesis of S. suis, there is still a lack of integration between epidemiological, molecular, and geographic data, particularly in regions such as Latin America (13, 15, 19). This gap limits a comprehensive understanding of its transmission dynamics within a One Health framework (19, 20).

Finally, one of the most relevant features of this pathogen is its ability to acquire and disseminate antimicrobial resistance, determinants through mobile genetic elements such as integrative and conjugative elements (ICEs), which facilitate horizontal gene transfer (21–24). Antimicrobial susceptibility patterns vary among drug classes and geographically, with resistance to macrolides, oxytetracyclines and aminoglycosides differing from that reported for beta-lactams and fluoroquinolones. These mechanisms have significantly contributed to the dissemination of resistance determinants in pig production systems, with implications for both animal and human health (6, 20–26).

2. Materials and methods

Necropsy

A standardized necropsy was performed on two 10-week-old terminal hybrid pigs from an intensive swine production system located in south-central Chile. The animals originated from a PIC genetic line (337 male × 1,020 female) and exhibited neurological signs characterized by lethargy, recumbency, generalized motor weakness, forelimb paraparesis, and decreased muscle tone in the hindlimbs. Both animals were humanely euthanized due to the severity of their clinical condition and were subsequently submitted for diagnostic postmortem examination. Tissue samples, including the brain, cerebellum, spinal cord, and lung, were collected during necropsy for microbiological and histopathological analyses.

Ethical review and approval were not required because this study was based on archived tissue specimens originally collected and submitted to the Veterinary Anatomic Pathology Service as part of routine diagnostic investigations. The animals were euthanized exclusively for clinical and diagnostic purposes, independently of the present study, and all samples were collected according to standard veterinary diagnostic procedures. No animals were euthanized, subjected to additional sampling, or exposed to experimental procedures specifically for the purposes of this study.

Histopathological examination

For histopathological evaluation, the collected samples were fixed in 10% neutral buffered formalin routinely processed, embedded in paraffin, sectioned at 4 μm, and stained with hematoxylin and eosin (H&E), according to the standard protocols of the Histopathology Laboratory of the University of Concepción. Histological sections were examined using an AXIOSCOP 40® microscope (Carl Zeiss, Germany) equipped with an integrated AxioCam 1,200 digital camera.

Microbiological culture isolation and identification

Standard microbiological procedures established by the Swine Diagnostic Laboratory at the University of Concepción were followed. Prior to aseptic tissues sampling, the physical work surface was disinfected with 70% ethanol to minimize potential environmental contamination. For lung samples, the tissue surface was cauterized using a flame-heated sterile metal spatula to minimize surface contamination. An incision was subsequently made through the cauterized area using a sterile scalpel, and a sterile swab was inserted into the underlying tissue for sample collection. For brain samples, the skull was opened carefully without disrupting the meninges. Subsequently, the meninges were incised using sterile scissors and forceps, and the exposed brain surface was sampled using a sterile swab.

Each swab was sequentially inoculated onto chocolate agar, blood agar, and MacConkey agar. The primary inoculum was streaked over approximately one-quarter of the agar surface, and isolation streaking was subsequently performed using a sterile bacteriological loop. Following plate inoculation, the same swab was transferred into 5 mL of Brain Heart Infusion (BHI) broth for enrichment.

Agar plates and BHI broth cultures were incubated at 37 °C for 24 h under aerobic conditions supplemented with 5% CO₂. Following incubation, representative β-hemolytic bacterial colonies were selected from blood agar and subjected to Gram staining and catalase testing, with the latter yielding a negative result. Based on colony characteristics, including the β-hemolytic phenotype observed on blood agar, Gram-staining morphology, and the negative catalase reaction, bacterial identification was subsequently performed using the API 20 Strep biochemical identification of the isolates.

Determination of minimum inhibitory concentration (MIC)

Minimum inhibitory concentration (MIC) testing was performed by an external laboratory, according to its established protocols. Official breakpoints were applied according to CLSI-VET01S ED:2024 and EUCAST Clinical Breakpoints 2024 (v14.0). Where applicable, results were additionally interpreted using epidemiological cutoff values (ECOFFs), MIC50 and MIC90 values obtained from the EUCAST MIC distribution database, and data from previous studies (27–33). Quality control was performed using standard ATCC reference strains as recommended in the corresponding guidelines. For the classification of antimicrobial resistance profiles, multidrug resistance (MDR) was defined as resistance to at least three different classes of antimicrobial agents (26).

Samples were subjected to serial cultures for 72 h in liquid enrichment media at 37 °C, followed by 72 h of incubation on selective and differential solid culture media under aerobic conditions supplemented with 5% CO₂ at 37 °C. Subsequently, bacterial isolates were incubated for 18 to 25 h for MIC determination using the Sensititre® automated system. Susceptibility was evaluated against the following antimicrobials by the MIC system: Spectinomycin, Gentamicin, Neomycin, Ampicillin/Amoxicillin, Ceftiofur, Penicillin, Florfenicol, Danofloxacin, Enrofloxacin, Clindamycin, Tilmicosin, Tulathromycin, Tylosin Tartrate, Tiamulin, Sulfadimethoxine, Trimethoprim/Sulfamethoxazole, Chlortetracycline, and Oxytetracycline.

3. Results

Macroscopic findings

Both pigs had a small volume of translucent, amber-colored serous fluid within the abdominal cavity, accompanied by occasional peritoneal adhesions. Pulmonary congestion and edema were observed in both animals. In addition, pig 1 exhibited multifocal petechial hemorrhages, interpreted as postmortem changes, while pig 2 showed bronchointerstitial pneumonia involving the dorsal regions of the right middle and caudal lung lobes. Renal medullary enlargement was observed in both pigs, with bilateral involvement in pig 1 and unilateral involvement of the right kidney in pig 2. Pig 1 also had a congenital cyst within the left renal pelvis, while pig 2 exhibited a congenital renal cyst measuring 1.2 cm in diameter. In both animals, the urinary bladder was mildly distended and contained translucent yellow urine.

Gastrointestinal findings differed between the two pigs. Pig 1 exhibited diffuse duodenal hyperemia and parakeratosis of the pars esophageal, with yellowish gastric contents, whereas pig 2 had yellow mucoid gastric contents and a focal ulcer in the glandular stomach, measuring approximately 7 mm in diameter. The liver and spleen were grossly unremarkable in both animals. Mild intestinal hyperemia was observed in pig 1, while no gross intestinal abnormalities were identified in pig 2. Moderate, diffuse cerebral hyperemia was present in both pigs (Figures 1A,B), with no significant gross abnormalities identified in the cerebellum or spinal cord. Finally, subcutaneous adipose tissue was considered adequate for the age of pig 1 but was scant in pig 2.

Histopathological findings

Both pigs exhibited non-suppurative inflammatory lesions within the central nervous system characterized by perivascular mononuclear cuffs. In pig 1, mild multifocal perivascular mononuclear cuffs composed predominantly of lymphocytes with occasional macrophages were observed within the gray matter of the spinal cord and the molecular layer of the cerebellum. Mild multifocal mononuclear leptomeningitis, extending into the adjacent perivascular spaces of the cerebellar cortex, was also present. No significant neuronal necrosis or suppurative inflammation was identified. These findings were consistent with mild multifocal non-suppurative meningoencephalomyelitis (see Figure 2).

In pig 2, the gray matter of the spinal cord exhibited moderate multifocal perivascular mononuclear cuffs composed predominantly of lymphocytes with occasional macrophages (Figures 3A,B). Mild vascular congestion was observed in the cerebellum (Figures 3C,D) and cerebrum without associated inflammatory infiltrates (Figures 3E,F). Overall, the lesions were consistent with moderate multifocal non-suppurative myelitis, predominantly affecting the spinal cord.

Microbiological culture isolation and identification

S. suis was isolated on blood and chocolate agar and recovered from BHI broth from the brain and spinal cord of pig 1. In pig 2, S. suis was isolated only from the brain. In addition, Pasteurella spp. was isolated from the lung of pig 2.

Minimum inhibitory concentration

The results of the MIC testing showed that the isolates from both pigs were susceptible to gentamicin (≤1 μg/mL). Additionally, the isolate from pig 1 was susceptible to danofloxacin (0.25 μg/mL), whereas the isolate from pig 2 was susceptible to trimethoprim/sulfamethoxazole and showed intermediate susceptibility to neomycin, danofloxacin, tulathromycin, and tiamulin. Finally, both isolates were resistant to Spectinomycin, Ampicillin/Amoxicillin, Ceftiofur, Penicillin, Florfenicol, Enrofloxacin, Clindamycin, Tilmicosin, Tylosin Tartrate, Sulfadimethoxine, Oxytetracycline, and Chlortetracycline (Table 1).

4. Discussion

Streptococcus suis has emerged as a zoonotic pathogen of global relevance, with substantial implications not only for swine production but also for human health (1, 2, 6, 8). The zoonotic risk is particularly relevant in certain occupational and cultural settings, where direct contact with pigs or their byproducts, especially in the presence of skin abrasions or wounds, represents an important route of infection. In addition, the consumption of raw or undercooked pork has been recognized as an important route of transmission (2, 8, 10, 17). The epidemiological distribution of human S. suis infections shows a marked concentration of cases in Asia, a pattern that has been associated, among other factors, with specific dietary practices and frequent exposure to pigs and pork products (8, 10, 11). Nevertheless, documented cases in Europe and the Americas, including human infections reported in Chile, demonstrate that S. suis infection is not restricted to specific endemic regions and further support its relevance as a globally distributed zoonosis (12–15, 17).

Regarding the lesions associated with S. suis infection in pigs, pathological findings consistent with meningitis, septicemia, arthritis, and endocarditis have been previously described (34, 35). In the present study, however, the clinical presentation was predominantly neurological, characterized by lethargy, paraparesis, and decreased muscle tone, with cerebral hyperemia observed at postmortem examination. Histopathological examination revealed cerebral hyperemia, meningoencephalomyelitis and myelitis, including nonsuppurative inflammatory changes and mononuclear perivascular cuffing. These findings differ to some extent from previous reports, in which fibrinosuppurative meningitis and myelitis have been more commonly described, whereas encephalitis and perivascular cuffing appear to be less frequently reported (34, 36). Moreover, some of the lesions reported in previous studies were described under experimental conditions or in the context of coinfections and infections caused by specific S. suis serotypes, which should be considered when comparing these findings with those observed in the present cases (34–39).

Antimicrobial resistance in S. suis should be interpreted from multiple perspectives while acknowledging the limitations of the present study. First, the inclusion of only two animals from a single farm and, consequently, only two S. suis isolates represents a major limitation and precludes extrapolation of the observed antimicrobial susceptibility profiles to the broader swine population in Chile. Additional limitations include the lack of molecular characterization of the isolates, particularly regarding serotyping and the detection of virulence-associated genes and antimicrobial resistance determinants.

These limitations were further compounded by resource constraints and limited access to specific diagnostic techniques, including PCR and identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Nevertheless, the antimicrobial susceptibility profiles observed in this study revealed resistance to multiple antimicrobial agents. Previous studies have associated similar resistance phenotypes with selective pressure, genetic diversity, and horizontal gene transfer; however, these mechanisms were not investigated in the isolates analyzed here (18–22, 40–42). Several studies have a reported a high prevalence of resistance to macrolides, sulfonamides, and tetracyclines, as well as an increasing frequency of multidrug-resistant (MDR) strains, both in sick animals and healthy carriers (23–26, 35, 40). Findings in Thailand and China show high resistance rates and the circulation of MDR strains exceeding 70%. Although direct comparison is limited by the small number of isolates examined here, both isolates showed resistance to several antimicrobial agents belonging to these classes, including tilmicosin, tylosin tartrate, sulfadimethoxine, oxytetracycline, and chlortetracycline (26, 35, 40).

One of the key factors underlying the epidemiology of antimicrobial resistance in S. suis is the presence of resistance determinants associated with mobile genetic elements, including transposons, plasmids, and integrative and conjugative elements (ICEs) (19, 21, 35). These elements facilitate horizontal gene transfer both among S. suis strains and, potentially, across bacterial species, thereby contributing to the dissemination and co-selection of antimicrobial resistance determinants (18–22). Experimental studies have shown that these elements can be transferred in bloc, generating combined resistance phenotypes, which is reflected in the frequent co-occurrence of genes such as tet(M) / tet(O) and erm(B), which are involved in tetracycline and macrolide resistance (18–20, 22). Other determinants have also been described, including optrA, which is associated with resistance to oxazolidinones and phenicols in S. suis, further illustrating the diversity of resistance mechanisms that this species can harbor (35). Because molecular analyses were not performed in the present study, the presence of these determinants cannot be established in the two isolates. Therefore, evidence from previous studies is presented as a framework for interpreting the phenotypic resistance patterns observed here rather than as an explanation of the mechanisms involved in these isolates.

At the molecular level, resistance in S. suis depends not only on gene acquisition of resistance genes but also on chromosomal mutations. Alterations in penicillin-binding proteins (PBP1a, PBP2x, and PBP2b), as well as mutations affecting the quinolone target enzymes GyrA and ParC, have been associated with reduced antimicrobial susceptibility (41).

Geographical variability in antimicrobial susceptibility has also been reported for trimethoprim/sulfamethoxazole. Resistance rates range from close to 0% in some European studies to substantially higher levels in Asian reports (23–26, 40). In the present study, the isolate from pig 2 was susceptible to trimethoprim/sulfamethoxazole. However, it is important to note that this antimicrobial is used to treat respiratory and gastrointestinal infections rather than neurological infections.

A similar geographical variability has been reported for tiamulin, a pleuromutilin (23, 24). Previous studies have associated this variability with differences in antimicrobial targets and the acquisition of specific resistance determinants, whose distribution is less consistent than that of associated genes with tetracycline and macrolide resistance (21, 23, 35). However, these mechanisms were not investigated in the present isolates. This variability was also evident in the present study, as the isolate from pig 1 was resistant, while the isolate from pig 2 showed intermediate susceptibility.

It is noteworthy that both isolates showed resistance to the beta-lactams evaluated in this study. This finding contrasts with much of the available literature, in which susceptibility to beta-lactams remains common among S. suis populations despite the emergence of resistant isolates (23–26, 40). Beta-lactam resistance in S. suis has been primarily associated with the alterations in penicillin-binding proteins (PBPs), particularly PBP1a, PBP2b, and PBP2x, rather than with the acquisition of horizontally transferable resistance genes (41) However, these mechanisms were not investigated in the isolates analyzed in the present study.

Regarding aminoglycosides, both isolates were susceptible to gentamicin. As with other antimicrobials susceptibility patterns vary worldwide and may be influenced by antimicrobial use patterns in swine production (11, 24). It may also be influenced by the distribution of resistance determinants such as aac(6′)-aph(2″), aph(3′)-IIIa, and aadE, compared with genes such as tet(M) or optrA, which are frequently reported in mobile genetic contexts in S. suis (19, 22, 26, 33, 41). However, the isolate from pig 2 showed intermediate susceptibility to tulathromycin, a macrolide. Both isolates were also resistant to spectinomycin, whereas the isolate from pig 2 showed intermediate susceptibility to neomycin. Together, these findings demonstrate phenotypic differences between the two isolates but do not allow conclusions regarding broader resistance patterns.

These differences are closely related to antimicrobial use patterns in swine production, where in Southeast Asian settings, particularly in Thailand, several studies have documented the widespread use of antibiotics for prophylactic and metaphylactic purposes, as well as the circulation of resistant and multidrug-resistant S. suis strains (11, 26, 40). These practices generate selective pressure on the bacterial microbiota, favoring the persistence of resistant strains (11, 24). In contrast, Europe has progressively implemented restrictive policies aimed at reducing antimicrobial use and promoting its prudent use in animal production. These measures include the prohibition of antimicrobials as growth promoters, restrictions on their prophylactic and metaphylactic use, and stricter regulation of prescription and therapeutic use. These measures include the prohibition of antimicrobials as growth promoters, restrictions on their prophylactic and metaphylactic use, and stricter regulation of prescription and therapeutic use. They are complemented by systematic surveillance programs monitoring antimicrobial consumption and bacterial resistance and by measures aimed at strengthening biosecurity, disease prevention, and livestock management practices (42, 43). This approach is also supported by recommendations from the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH), as well as the European Union’s regulatory framework, within a One Health perspective (43–45). In countries with well-established antimicrobial management and surveillance programs, such as Denmark, these interventions have been associated with substantial reductions in antimicrobial consumption in animal production and improved control of antimicrobial resistance (24, 25).

In Chile, although the available evidence remains limited, the presence of S. suis has been documented in both swine populations and humans (14–17). The first cases of S. suis -associated meningitis reported in workers involved in pig production highlighted the occupational nature and zoonotic potential of this pathogen (15), while additional human cases associated with pork handling further support the relevance of exposure routes beyond direct contact with pigs on farms (17). Although antimicrobial treatment was described in these reports, national data on S. suis antimicrobial susceptibility profiles remain scarce. In this context, it is particularly noteworthy that porcine isolates previously reported in Chile were susceptible to penicillin (15–17), whereas both isolates analyzed in the present study were classified as resistant to this antimicrobial based on MIC results. Furthermore, the identification of S. suis isolates in different national studies, including genetically related strains within the areas investigated, confirms the circulation of this pathogen in Chile and underscores the need for strengthened epidemiological surveillance (14, 16).

The limited number of studies characterizing antimicrobial resistance among Chilean S. suis isolates makes it difficult to determine whether resistance mechanisms widely described internationally are also present and distributed among bacterial populations circulating in Chile (16, 19–22, 41, 42). Additionally, the MIC panel used in the present study did not include certain antimicrobials of interest, such as amoxicillin as an individual agent and doxycycline, thereby limiting a more comprehensive characterization of the antimicrobial susceptibility profiles. Although regulations governing antimicrobial use in animal production have advanced in recent years (43–45), a substantial gap remains in the generation of S. suis -specific antimicrobial resistance data. This lack of information limits comparisons with other regions and hinders assessment of temporal trends in resistance and their potential relationship with implemented control measures. Therefore, although international evidence indicates that S. suis can harbor a diverse range of antimicrobial resistance determinants and associated mobile genetic elements (19–22, 41, 42), their presence, distribution, and epidemiological relevance among isolates circulating in Chile remain to be determined through dedicated phenotypic and molecular studies.

Another noteworthy finding was that neither isolate was susceptible to all antimicrobial agents evaluated. Although the limited number of isolates precludes broader conclusions, this observation is consistent with previous reports describing the widespread occurrence of antimicrobial resistance among S. suis populations (23–27, 40, 42). Beyond its role as an important swine pathogen, S. suis has also been recognized as a potential reservoir of antimicrobial resistance determinants, some of which are associated with mobile genetic elements and may contribute to horizontal gene transfer between bacterial populations (18–22, 41). These characteristics further underscore the relevance of S. suis antimicrobial resistance from a One Health perspective (18, 42–46). Based on their phenotypic susceptibility profiles, the two isolates analyzed here exhibited resistance to multiple antimicrobial classes and would meet previously proposed definitions of multidrug resistance (47). While the lack of comprehensive genetic characterization represents a significant limitation, our findings, along with the available evidence, support the view that antimicrobial resistance in S. suis is a complex and dynamic evolutionary phenomenon shaped by the selective pressure imposed by antimicrobial use (11, 24, 43–45). Chile is not exempt from this global challenge (14–17); however, the scarcity of national studies addressing S. suis and its antimicrobial susceptibility profiles limits our understanding of the extent and distribution of antimicrobial resistance in Chilean swine populations. This represents a significant knowledge gap and highlights the need for more epidemiological, phenotypic, and molecular studies at the national level.

Statements

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Data availability

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author/s.

Ethics approval

Ethical approval was not required for the study involving animals in accordance with the local legislation and institutional requirements because this study used archived tissue specimens submitted to the Veterinary Anatomic Pathology Service as part of routine diagnostic investigations.

Author contributions

FL-M: Conceptualization, Methodology, Resources, Visualization, Writing – review & editing. FV-M: Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing. ÁR-G: Conceptualization, Methodology, Supervision, Writing – review & editing.

Acknowledgements

We express our appreciation to Daniela Rojas Mansilla and Cecilia Contreras Muñoz for their technical assistance. The technical support offered by the Histopathology Laboratory and Porcine Laboratory and of University of Concepción, Chillán (Chile), using routine diagnostic cases submitted to the Animal Pathology Service, University of Concepción.

References

  1. 1. Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. (2014) 3: e45. doi:, doi:10.1038/emi.2014.45
  2. 2. Dutkiewicz J, Sroka J, Zając V, Wasiński B, Cisak E, Sawczyn A. Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I - epidemiology. Ann Agric Environ Med. (2017) 24: 683 – 95. doi:, doi:10.26444/aaem/79813
  3. 3. Segura M, Fittipaldi N, Calzas C, Gottschalk M. Critical Streptococcus suis virulence factors: are they all really critical? Trends Microbiol. (2017) 25: 585 – 99. doi:, doi:10.1016/j.tim.2017.02.005
  4. 4. Segura M, Calzas C, Grenier D, Gottschalk M. Initial steps of the pathogenesis of the infection caused by Streptococcus suis: fighting against nonspecific defenses. FEBS Lett. (2016) 590: 3772 – 99. doi:, doi:10.1002/1873-3468.12364
  5. 5. Fittipaldi N, Segura M, Grenier D, Gottschalk M. Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol. (2012) 7: 259 – 79. doi:, doi:10.2217/fmb.11.149
  6. 6. Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. (2010) 5: 371 – 91. doi:, doi:10.2217/fmb.10.2
  7. 7. Kong D, Chen Z, Wang J, Lv Q, Jiang H, Zheng Y. Interaction of factor H-binding protein of Streptococcus suis with globotriaosylceramide promotes the development of meningitis. Virulence. (2017) 8: 1290 – 302. doi:, doi:10.1080/21505594.2017.1317426
  8. 8. Huong VT, Ha N, Huy NT, Horby P, Nghia HD, Thiem VD. Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans. Emerg Infect Dis. (2014) 20: 1105 – 14. doi:, doi:10.3201/eid2007.131594
  9. 9. Tang J, Wang C, Feng Y, Yang W, Song H, Chen Z. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med. (2006) 3: e151. doi:, doi:10.1371/journal.pmed.0030151
  10. 10. Kerdsin A. Human Streptococcus suis infections in Thailand: epidemiology, clinical features, genotypes, and susceptibility. Trop Med Infect Dis. (2022) 7: 359. doi:, doi:10.3390/tropicalmed7110359
  11. 11. Lekagul A, Tangcharoensathien V, Mills A, Rushton J, Yeung S. How antibiotics are used in pig farming: a mixed-methods study of pig farmers, feed mills and veterinarians in Thailand. BMJ Glob Health. (2020) 5: e001918. doi:, doi:10.1136/bmjgh-2019-001918
  12. 12. Brizuela J, Roodsant TJ, Hasnoe Q, van der Putten BCL, Kozakova J, Slotved HC. Molecular epidemiology of underreported emerging zoonotic pathogen Streptococcus suis in Europe. Emerg Infect Dis. (2024) 30: 413 – 22. doi:, doi:10.3201/eid3003.230348
  13. 13. Bakpatina-Batako MVP, Li K, Lacouture S, Cipolla L, Gianecini A, Prieto M. Human Streptococcus suis infections, South America, 1995–2024. Emerg Infect Dis. (2025) 31: 1277 – 86. doi:, doi:10.3201/eid3107.241835
  14. 14. Alarcón LP, Araya RP, Aguayo C, Fernández J, Illesca V, Zaror A. Confirmación de Streptococcus suis en Chile. Rev Chil Infectol. (2013) 30: 539 – 40. doi: doi:10.4067/S0716-10182013000500011
  15. 15. Koch E, Fuentes G, Carvajal R, Palma R, Aguirre V, Cruz C. Meningitis bacteriana aguda por Streptococcus suis en criadores de cerdos: comunicación de los primeros dos casos en Chile. Rev Chil Infectol. (2013) 30: 557 – 61. doi: doi:10.4067/S0716-10182013000500015
  16. 16. Morales B, Ruiz Á, Lacouture S, Gottschalk M. Clonal distribution of Streptococcus suis isolated from diseased pigs in the central region of Chile. Can J Vet Res. (2015) 79: 343 – 6.
  17. 17. Moraga J, Fica A, Navarrete B, Henríquez R, Navarrete-Asenjo C. Meningitis e hipoacusia por manipulación de carne porcina. Rev Chil Infectol. (2018) 35: 731 – 2. doi:, doi:10.4067/S0716-10182018000600731
  18. 18. Uruén C, Lavilla MJ, Libante V, Marín CM, Rezusta A, Payot S. Evidence of transfer of antimicrobial resistance genes from the porcine pathogen Streptococcus suis to human clinical isolates of Streptococcus agalactiae in a major pig-producing region of Spain. One Health. (2026) 22: 101396. doi:, doi:10.1016/j.onehlt.2026.101396
  19. 19. Libante V, Nombre Y, Coluzzi C, Staub J, Guédon G, Gottschalk M. Chromosomal conjugative and mobilizable elements in Streptococcus suis: major actors in the spreading of antimicrobial resistance and bacteriocin synthesis genes. Pathogens. (2019) 9: 22. doi:, doi:10.3390/pathogens9010022
  20. 20. Pan Z, Liu J, Zhang Y, Chen S, Ma J, Dong W. A novel integrative conjugative element mediates transfer of multi-drug resistance between Streptococcus suis strains of different serotypes. Vet Microbiol. (2019) 229: 110 – 6. doi: doi:10.1016/j.vetmic.2018.11.028
  21. 21. Huang J, Ma J, Shang K, Hu X, Liang Y, Li D. Evolution and diversity of the antimicrobial resistance associated mobilome in Streptococcus suis: a probable mobile genetic elements reservoir for other streptococci. Front Cell Infect Microbiol. (2016) 6: 118. doi:, doi:10.3389/fcimb.2016.00118
  22. 22. Duan H, Ren S, Zhang H, Yu R, Liu Z, Du X. Horizontal transfer of drug resistance genes carried by ICE_Prophage in Streptococcus suis SC124. Acta Vet Zootech Sin. (2024) 55: 3699 – 705. doi: doi:10.11843/j.issn.0366-6964.2024.08.041
  23. 23. Dechêne-Tempier M, Jouy E, Bayon-Auboyer MH, Bougeard S, Chauvin C, Libante V. Antimicrobial resistance profiles of Streptococcus suis isolated from pigs, wild boars, and humans in France between 1994 and 2020. J Clin Microbiol. (2023) 61: e00164 – 23. doi:, doi:10.1128/jcm.00164-23
  24. 24. Holmer I, Salomonsen CM, Jorsal SE, Astrup LB, Jensen VF, Høg BB. Antibiotic resistance in porcine pathogenic bacteria and relation to antibiotic usage. BMC Vet Res. (2019) 15: 449. doi:, doi:10.1186/s12917-019-2162-8
  25. 25. de Jong A, Morrissey I, Rose M, Temmerman R, Klein U, Simjee S. Antimicrobial susceptibility among respiratory tract pathogens isolated from diseased cattle and pigs from different parts of Europe. J Appl Microbiol. (2023) 134: lxad132. doi:, doi:10.1093/jambio/lxad132
  26. 26. Yongkiettrakul S, Maneerat K, Arechanajan B, Malila Y, Srimanote P, Gottschalk M. Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs, asymptomatic pigs, and human patients in Thailand. BMC Vet Res. (2019) 15: 5. doi:, doi:10.1186/s12917-018-1732-5
  27. 27. Vela AI, Moreno MA, Cebolla JA, González S, Latre MV, Domínguez L. Antimicrobial susceptibility of clinical strains of Streptococcus suis isolated from pigs in Spain. Vet Microbiol. (2005) 105: 143 – 7. doi:, doi:10.1016/j.vetmic.2004.10.009
  28. 28. Li LL, Liao XP, Sun J, Yang YR, Liu BT, Yang SS. Antimicrobial resistance, serotypes, and virulence factors of Streptococcus suis isolates from diseased pigs. Foodborne Pathog Dis. (2012) 9: 583 – 8. doi:, doi:10.1089/fpd.2011.1106
  29. 29. van Hout J, Heuvelink A, Gonggrijp M. Monitoring of antimicrobial susceptibility of Streptococcus suis in the Netherlands, 2013–2015. Vet Microbiol. (2016) 194: 5 – 10. doi:, doi:10.1016/j.vetmic.2016.03.014
  30. 30. Niemann L, Müller P, Brauns J, Nathaus R, Schäkel F, Kipschull K. Antimicrobial susceptibility and genetic relatedness of respiratory tract pathogens in weaner pigs over a 12-month period. Vet Microbiol. (2018) 219: 165 – 70. doi:, doi:10.1016/j.vetmic.2018.03.030
  31. 31. Ichikawa T, Oshima M, Yamagishi J, Muramatsu C, Asai T. Changes in antimicrobial resistance phenotypes and genotypes in Streptococcus suis strains isolated from pigs in the Tokai area of Japan. J Vet Med Sci. (2020) 82: 9 – 13. doi:, doi:10.1292/jvms.19-0449
  32. 32. Werinder A, Aspán A, Backhans A, Sjölund M, Guss B, Jacobson M. Streptococcus suis in Swedish grower pigs: occurrence, serotypes, and antimicrobial susceptibility. Acta Vet Scand. (2020) 62: 36. doi:, doi:10.1186/s13028-020-00533-3
  33. 33. Vilaró A, Novell E, Enrique-Tarancon V, Balielles J, Migura-García L, Fraile L. Antimicrobial susceptibility testing of porcine bacterial pathogens: investigating the prospect of testing a representative drug for each antimicrobial family. Antibiotics (Basel). (2022) 11: 638. doi:, doi:10.3390/antibiotics11050638
  34. 34. Hennig-Pauka I, Imker R, Mayer L, Brügmann M, Werckenthin C, Weber H. From stable to lab-investigating key factors for sudden deaths caused by Streptococcus suis. Pathogens. (2019) 8: 249. doi:, doi:10.3390/pathogens8040249
  35. 35. Hammerschmitt ME, Bernardi ML, Wentz I, Bortolozzo FP, Mellagi APG, Franzo G. Clinical and pathological aspects of an outbreak of Streptococcus suis serotype 9 infection in pigs. Pesq Vet Bras. (2022) 42: e07004. doi: doi:10.1590/1678-5150-PVB-7004
  36. 36. Seele J, Tauber SC, Bunkowski S, Baums CG, Valentin-Weigand P, de Buhr N. The inflammatory response and neuronal injury in Streptococcus suis meningitis. BMC Infect Dis. (2018) 18: 297. doi:, doi:10.1186/s12879-018-3206-6
  37. 37. Zhang C, Zhang P, Wang Y, Fu L, Liu L, Xu D. Capsular serotypes, antimicrobial susceptibility, and the presence of transferable oxazolidinone resistance genes in Streptococcus suis isolated from healthy pigs in China. Vet Microbiol. (2020) 247: 108750. doi:, doi:10.1016/j.vetmic.2020.108750
  38. 38. Obradovic MR, Segura M, Segalés J, Gottschalk M. Review of the speculative role of co-infections in Streptococcus suis -associated diseases in pigs. Vet Res. (2021) 52: 49. doi:, doi:10.1186/s13567-021-00918-w
  39. 39. Lunha K, Chumpol W, Samngamnim S, Jiemsup S, Assavacheep P, Yongkiettrakul S. Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs in Thailand, 2018-2020. Antibiotics (Basel). (2022) 11: 410. doi:, doi:10.3390/antibiotics11030410
  40. 40. Palmieri C, Varaldo PE, Facinelli B. Streptococcus suis, an emerging drug-resistant animal and human pathogen. Front Microbiol. (2011) 2: 235. doi:, doi:10.3389/fmicb.2011.00235
  41. 41. Liu F, Zhang S, Erdeljan M, Zhang Y, Chen Z, Li J. Streptococcus suis: epidemiology and resistance evolution of an emerging zoonotic bacteria. One Health. (2025) 21: 101098. doi:, doi:10.1016/j.onehlt.2025.101098
  42. 42. World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization. (2015). Available online at: (Accessed May 27, 2026)
  43. 43. World Organisation for Animal Health. Terrestrial Animal Health Code: Antimicrobial Resistance. Paris: WOAH. (2024). Available online at: (Accessed May 27, 2026)
  44. 44. European Parliament, Council of the European Union. Regulation (EU) 2019/6 on veterinary medicinal products. Off J Eur Union. (2019) L4: 43 – 167.
  45. 45. Mader R EU-JAMRAI, Bourély C, Amat JP, Broens EM, Busani L. Defining the scope of the European antimicrobial resistance surveillance network in veterinary medicine (EARS-vet): a bottom-up and one health approach. J Antimicrob Chemother. (2022) 77: 816 – 26. doi:, doi:10.1093/jac/dkab462
  46. 46. Segura M, Aragon V, Brockmeier SL, Gebhart C, Greeff A, Kerdsin A. Update on Streptococcus suis research and prevention in the era of antimicrobial restriction: 4th international workshop on S. suis. Pathogens. (2020) 9: 374. doi:, doi:10.3390/pathogens9050374
  47. 47. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. (2012) 18: 268 – 81. doi:, doi:10.1111/j.1469-0691.2011.03570.x

Citation

Larenas-Muñoz, F., et al. (2026). Antimicrobial resistance profiling of Streptococcus suis isolated from neurological cases in Chilean pigs. Frontiers in Veterinary Science, Volume 13. https://doi.org/
Received
Accepted
Published
Volume
13 - 2026

Copyright

Copyright © 2026 Larenas-Muñoz, Videla-Martínez and Ruiz-Garrido.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Álvaro Ruiz-Garrido

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0